期刊文献+

自身免疫性大疱性皮肤病的实验诊断 被引量:3

Laboratory diagnosis of autoimmune blistering skin diseases
原文传递
导出
摘要 自身免疫性大疱性皮肤病是一组器官特异性自身免疫性疾病,患者血清中有针对皮肤连接结构桥粒、半桥粒的自身抗体,破坏皮肤连接而形成以皮肤及黏膜水疱、大疱为主要特征的疾病。不同的自身抗体导致水疱发生的位置不同,可分为表皮内及表皮下大疱性皮肤病两大类,这两类疾病所采取的治疗方案不同、预后差别较大。根据临床表现及组织病理尚不足以明确自身免疫性大疱性皮肤病的诊断,结合直接免疫荧光、间接免疫荧光、ELISA、免疫印迹及免疫沉淀等免疫学检测技术能够更准确地诊断。同时,对血清的检测还可用于评估病情的活动度并用于指导治疗。 Autoimmune blistering skin diseases are a group of organ-specific autoimmune disorders that are characterized by autoantibodies against desmosome and hemidesmosome which are structural proteins of the epidermis or the dermal-epidermal junction and clinically by blisters and erosions on skin and/or mucous membranes. According to the skin level at which the blister occurs and the structural proteins that the autoantibodies target, autoimmune blistering diseases can be categorized into intraepithelial blister group and subepidermal blister group. The treatment options and prognosis are different among the various diseases. Since clinical criteria and histopathological characteristics are not sufficient for an accurate diagnosis of autoimmune blistering skin diseases, direct immunofluorescence microscopy, indirect immunofluorescence microscopy, ELISA, immunoblotting and immunoprecipitation are needed for exact diagnosis. The detection of serum autoantibodies have been shown to correlate with disease activity and thus may be helpful in deciding treatment options for the patients.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2015年第12期797-800,共4页 Chinese Journal of Laboratory Medicine
基金 国家自然科学基金(81101190,81170035) 武汉晨光计划(2014070404010225) 武汉市卫生局课题(WX12A12)
关键词 自身免疫疾病 皮肤疾病 水疱大疱性 自身抗体 免疫测定 Autoimmune diseases Skin diseases, vesiculobullous Autoantibodies Immunoassay
  • 相关文献

参考文献12

  • 1Baum S, Sakka N, Artsi O, et al. Diagnosis and classification of autoimmune blistering diseases[ J]. Autoimmun Rev, 2014, 13 (4-5) : 482-489.
  • 2Otten JV, Hashimoto T, Hertl M, et al. Molecular diagnosis in autoimmune skin blistering conditions[ J]. Curt Mol Med, 2014, 14( 1 ) : 69-95.
  • 3Bolognia JL, Jorizzo JL, Rapini RP. Dermatology [M]. Spain : Elsevier Ltd, 2008: 403-488.
  • 4Goletz S, Hashimoto T, Zillikens D, et al. Anti-p200 pemphigoid [ J ]. J Am Aead Dermatol, 2014, 71 ( 1 ) : 185-191.
  • 5Sehmidt E, Zillikens D. The diagnosis and treatment of autoimmune blistering skin diseases[ J]. Dtseh Arztebl Int, 2011, 108 (23) : 399-405, I-III.
  • 6Arbache ST, Nogueira TG, Delgado L, et al. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience [J]. An Bras Dermatol, 2014, 89(6): 885-88Q.
  • 7陈金波,王宝玺,李永哲.自身免疫性大疱性皮肤病四例诊断与治疗评析[J].中华检验医学杂志,2008,31(1):107-110. 被引量:1
  • 8van Beek N, Rentzsch K, Probst C, et al. Serological diagnosis of autoimmune bullous skin diseases : prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy [J]. Orphanet J Rare Dis, 2012, 7: 49.
  • 9Mortazavi H, Khatami A, Seyedin Z, et al. Salivary desmoglein enzyme-linked immunosorbent assay for diagnosis of pemphigus vulgaris: a noninvasive alternative test to serum assessment [ J]. Biomed Res Int, 2015, 2015 : 698310.
  • 10Lee EH, Kim YH, Kim S, et al. Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BPI80 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid[J]. Ann Dermatol, 2012, 24(1): 45-55.

二级参考文献9

  • 1Hertl M. Autoimmune Diseases of the skin: Pathogenesis, Diagnosis, Management. 2nd ed. Austria: Springer Wien New York, 2005:45-132.
  • 2Burns T, Breathnach S, Cox N, et al. Rook's Textbook of Dermatology. 7th ed. London: Blackwell Science, 2004: 1-41, 58.
  • 3Kanitakis J. Indirect immunofluorescence microscopy for the serological diagnosis of autoimmune blistering skin diseases: a review. Clin Dermatol, 2001,19:614-621.
  • 4Freedberg IM, Elisen AZ, Wolff K, et al. Fitzpatrick' s Dermatology in General Medicine. 6th ed. New York : MC Graw Hill, 2003:543-632.
  • 5Megahed M. Histopathology of Blistering Diseases with clinical, electron microscopic, immunological and molecular biological correlations. Berlin Heidelberg: Springer,2004 : 155-237.
  • 6Amagai M, Komai A, Hashimoto T, et al. Usefulness of enzymelinked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol, 1999,140:351- 357.
  • 7Zillikens D, Mascaro JM, Rose PA, et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol, 1997,109:679-683.
  • 8Yoshida M, Hamada T, Amagai M, et al. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci, 2006,41:21-30.
  • 9McKee PH, Calonje E, Granter SR. Pathology of the skin, with clinical correlations. 3rd ed. Philadelphia: Elsevier, 2005 : 81- 170.

同被引文献27

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部